Pneumotussin 2.5 Interactions
There are 576 drugs known to interact with Pneumotussin 2.5 (guaifenesin / hydrocodone), along with 16 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 209 are major, 366 are moderate, and 1 is minor.
- View all 576 medications that may interact with Pneumotussin 2.5
- View Pneumotussin 2.5 alcohol/food interactions (1)
- View Pneumotussin 2.5 disease interactions (16)
Most frequently checked interactions
View interaction reports for Pneumotussin 2.5 (guaifenesin / hydrocodone) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen / hydrocodone
- acetaminophen / oxycodone
- Afrin (oxymetazoline nasal)
- albuterol
- Allegra (fexofenadine)
- alprazolam
- amphetamine / dextroamphetamine
- Astepro (azelastine nasal)
- Avelox (moxifloxacin)
- azathioprine
- Azithromycin Dose Pack (azithromycin)
- Azo-Standard (phenazopyridine)
- bacitracin topical
- benzocaine topical
- benzonatate
- bethanechol
- Bromday (bromfenac ophthalmic)
- bupropion
- calcium citrate
- Campho-Phenique Maximum Strength (bacitracin / diperodon / neomycin / polymyxin b topical)
- carisoprodol
- Celebrex (celecoxib)
- cephalexin
- clindamycin topical
- clonazepam
- doxycycline
- Lyrica (pregabalin)
- promethazine
- Zyrtec (cetirizine)
Pneumotussin 2.5 alcohol/food interactions
There is 1 alcohol/food interaction with Pneumotussin 2.5 (guaifenesin / hydrocodone).
Pneumotussin 2.5 disease interactions
There are 16 disease interactions with Pneumotussin 2.5 (guaifenesin / hydrocodone) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
More about Pneumotussin 2.5 (guaifenesin / hydrocodone)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.